Latest Cerebral aneurysm Stories
Treatment guidelines updated for aneurysmal subarachnoid hemorrhage Patients who are diagnosed in the emergency room with a specific type of brain bleed should be considered for immediate transfer to a hospital that treats at least 35 cases a year, according to a new scientific statement from the American Heart Association/American Stroke Association. The Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage (aSAH) is published online in Stroke, an American Heart...
HOUSTON, April 16, 2012 /PRNewswire/ -- Kingwood Medical Center and The Joe Niekro Foundation are proud to present the third annual Knuckle Ball...A Pitch for Life. The annual event honors the beloved 13-year Houston Astros All-Star, Joe Niekro who died suddenly on October 27, 2006 from a ruptured brain aneurysm. Niekro's daughter, Natalie, created The Joe Niekro Foundation in his memory to raise funds for brain aneurysm research, treatment, awareness campaigns and support for...
LOS ANGELES, April 9, 2012 /PRNewswire/ -- NeuroSigma, Inc., a Los Angeles-based medical device company, today announced it has been awarded a Phase I NIH-STTR grant from the National Institute of Neurological Disorders and Stroke (NINDS) for the further development of its Thin-Film Nitinol (TFN)-covered stent for the potential treatment of brain aneurysms. Mayo Clinic is the sponsored research institution in this STTR grant. The TFN-covered stent technology was developed at the...
Researchers seek to determine if newly FDA approved gel-coated coils are more effective than the current standard bare platinum coils for aneurysm treatment CHICAGO, April 3, 2012 /PRNewswire-USNewswire/ -- Approximately 6 million Americans have brain aneurysms, a condition that occurs when a weak or thin spot develops on a blood vessel in the brain causing it to balloon. Often, these do not cause symptoms and go undetected, but every year an estimated 30,000 Americans experience...
New research from the University of Calgary's Hotchkiss Brain Institute shows that by using a CT scan (computerized tomography), doctors can predict which patients are at risk of continued bleeding in the brain after a stroke. This vital information will allow doctors to utilize the most powerful blood clotting medications for those with the highest risk. One in three individuals will continue to accumulate blood in the brain from a leak in a small artery. Pooling blood in the brain has...
ALISO VIEJO, Calif., March 6, 2012 /PRNewswire/ -- Sequent Medical, Inc. announced today that it has closed a $26.0 million Series C venture capital financing. Delphi Ventures led the financing and was joined by existing investors Versant Ventures, US Venture Partners, and Domain Associates. James Bochnowski of Delphi Ventures will join Sequent Medical's Board of Directors. "We are fortunate to have a strong consortium of life science venture capital firms and would like to welcome...
Wake Forest Baptist Medical Center HealthWire WINSTON-SALEM, N.C., Feb. 28, 2012 /PRNewswire-USNewswire/ -- Medical stories have the ability to defy belief. And then there's the tale of Zach Valentine. (Logo: http://photos.prnewswire.com/prnh/20111114/DC06171LOGO ) Who in the course of a couple of weeks last summer went from a romantic night with his wife to blinding pain in his head to a complex brain surgery in which his doctor, neurosurgeon John Wilson of Wake Forest...
An innovative approach to genome screening has provided clues about rare mutations that may make people susceptible to brain aneurysms, predisposing them to brain bleeds, according to preliminary late-breaking research presented at the American Stroke Association’s International Stroke Conference 2012. For the first time, scientists applied a process called whole exome sequencing to seek gene mutations in families in which multiple relatives have intracranial aneurysms, a condition in...
An experimental drug, clazosentan, reduced the risk of blood vessel spasm in patients with a brain aneurysm, according to research presented at the American Stroke Association's International Stroke Conference 2012. In patients with a subarachnoid hemorrhage, even after the burst weak spot in the vessel is closed, irritation from the initial bleeding can cause blood vessels to constrict, cutting off normal blood supply and resulting in even more brain damage. This is often called a "second...
TORONTO, Jan. 30, 2012 /PRNewswire-iReach/ -- NoNO, Inc., a Canadian biotechnology company, announced that the final results of the ENACT Phase 2 clinical trial of their novel stroke drug, NA-1, will be presented by the trial principal investigator, Dr. Michael D. Hill, in Session IX: Late Breaking Science Oral Abstracts, Room R03-05 at the International Stroke Conference in New Orleans on February 2, 2012 at 2:24 pm. This trial executed a novel clinical trial protocol aimed at...
